U.S. Food & Drug Administration 10903 New Hampshire Avenue: Silver Spring, MD 20993
U.S. Food & Drug Administration 10903 New Hampshire Avenue: Silver Spring, MD 20993
U.S. Food & Drug Administration 10903 New Hampshire Avenue: Silver Spring, MD 20993
Argie Zoubroulis
Quality Manager
124 Gaither Drive Suite # 140
Mt. Laurel, New Jersey 08054
Re: K172137
Trade/Device Name: PIEZOTOME CUBE
Regulation Number: 21 CFR 872.4120
Regulation Name: Bone Cutting Instrument and Accessories
Regulatory Class: Class II
Product Code: DZI
Dated: March 23, 2018
Received: April 3, 2018
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced
above and have determined the device is substantially equivalent (for the indications for use stated in the
enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the
enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance
with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a
premarket approval application (PMA). You may, therefore, market the device, subject to the general
controls provisions of the Act. The general controls provisions of the Act include requirements for annual
registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding
and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties.
We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be
subject to additional controls. Existing major regulations affecting your device can be found in the Code of
Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements
concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA
has made a determination that your device complies with other requirements of the Act or any Federal
statutes and regulations administered by other Federal agencies. You must comply with all the Act's
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good
manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820);
and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR
1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part
807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part
803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's
Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
For comprehensive regulatory information about medical devices and radiation-emitting products, including
information about labeling regulations, please see Device Advice
(https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn
(http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and
Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website
(http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone
(1-800-638-2041 or 301-796-7100).
Sincerely,
Mary S. Runner -S
For Tina Kiang, Ph.D.
Acting Director
Division of Anesthesiology,
General Hospital, Respiratory,
Infection Control, and Dental Devices
Office of Device Evaluation
Center for Devices and Radiological Health
Enclosure
DEPARTMENT OF HEALTH AND HUMAN SERVICES Form Approved: OMB No. 0910-0120
Food and Drug Administration Expiration Date: 06/30/2020
Indications for Use See PRA Statement below.
Device Name
PIEZOTOME CUBE
This section applies only to requirements of the Paperwork Reduction Act of 1995.
*DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*
The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
PRAStaff@fda.hhs.gov
“An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB number.”
FORM FDA 3881 (7/17) Page 1 of 1 PSC Publishing Services (301) 443-6740 EF
006 – 510(k) Summary (SMDA Requirements)
S001_Additional Information
510(k) Summary
[As Required by 21 CFR 807.92.c]
K172137
I – SUBMITTER
SATELEC
17, Avenue Gustave Eiffel
BP 30216
33708 Merignac Cedex
France
Telephone: 011-33-556-340-607
Fax: 011-33-556-349-292
email: philippe.girard@acteongroup.com
Argie ZOUBROULIS
SATELEC
c/o ACTEON, Inc.
124 Gaither Drive, Suite 140
Mt. Laurel, NJ 08054
Telephone: 800-289-6367 Ext. 390
Fax: 856-222-4726
Email: argie.zoubroulis@acteongroup.com
II – DEVICE
The Substantial Equivalence (SE) of PIEZOTOME CUBE is based on the Predicate Device identified in
the Table 01.
PIEZOTOME SOLO
SATELEC DZI K112188 Feb 03, 2012
PIEZOTOME SOLO LED
IV –DEVICE DESCRIPTION
SATELEC CUBE is an piezoelectric device that uses micro-vibrations of associated Tips, to perform the
dental procedures defined in Indication for Use.
The Console is the heart of the SATELEC PIEZOTOME CUBE. The Console contains the display board
and the motherboard. Ultrasonic Handpiece and Footswitch are connected to the Console. The Touch
screen present on the front panel is used to define the settings of the SATELEC PIEZOTOME CUBE
(Ultrasonic modes, irrigation flow values).
The Ultrasonic Handpiece is held in the Practitioner’s hand. The Ultrasonic Handpiece is connected to
the Console via a Handpiece Cord. The Handpiece is dedicated to Dental Bone Surgery procedures.
The Ultrasonic Handpiece is equipped with a Piezoelectric Transducer. The Piezoelectric transducer
converts the Electrical Signal delivered by the Console into mechanical micro-vibrations. The Ultrasonic
Handpiece is reusable and Sterilizable by autoclaving.
Tips are fixed by means of a Wrench at the extremity of the Ultrasonic Handpiece. Tip are in direct
contact to the patient. The ultrasonic mechanical vibrations are transmitted to the Tip.
The Pump housing is designed to accommodate SATELEC Irrigation Tubing cassettes. Irrigation
Tubings are Single Use and delivered under Sterile State. Irrigation Solution is intended to cool the
clinical site and rinse the fragments such as bone or teeth.
The PIEZOTOME CUBE is an ultrasonic surgical system that supply utilities to and serve as a base for
dental tips. The PIEZOTOME CUBE consist of a control unit and handpiece intended for use in intraoral
surgery procedures, including osteotomy, osteoplasty, periodontics and implantology.
A comparison Between SATELEC PIEZOTOME CUBE and the Predicate Device is present in Table
02.
Table 02 – Comparison Between SATELEC PIEZOTOME CUBE and the Predicate Device
Predicate Device #1
New Device
(PD#1)
Impact of the differences
Trade /
PIEZOTOME CUBE PIEZOTOME SOLO on Safety /
Device Name
Effectiveness
Knumber K172137 K112188
The intended use of the
The PIEZOTOME CUBE SATELEC PIEZOTOME
is an ultrasonic surgical SOLO (or PIEZOTOME
system that supply SOLO LED available in
utilities to and serve as a option) is to supply
base for dental tips. The utilities to and serve as a
PIEZOTOME CUBE base for dental tools and
Indication for Use consist of a control unit accessories for use by Similar to PD#1 - No Impact
and handpiece intended qualified dental
for use in intraoral practitioners.
surgery procedures,
including osteotomy,
osteoplasty, periodontics
and implantology.
The intended use of the
The intended use of the PIEZOTOME SOLO is to
SATELEC PIEZOTOME supply utilities to and
CUBE is to supply utilities serve as a base for
and to serve as a base for dental tools and
Intended Use Similar to PD#1 - No Impact
dental tools and accessories for use by
accessories for use by qualified dental
qualified dental practitioners. The
practitioners. PIEZOTOME SOLO is a
device designed to
perform dental surgery
including osteotomies,
osteoplasties,
periodontal
and implant
surgery.
A lot of features and characteristics of PIEZOTOME CUBE are identical to the Predicate Device #1. The
Identified differences have no impact on the Substantial Equivalence. Moreover, the identified Major
Changes have no impact on the Substantial Equivalence.
Electromagnetic Compatibility Test: The Electromagnetic Compatibility Tests have been performed
according to IEC 60601-1-2:2014, Medical electrical equipment - Part 1-2: General
requirements for basic safety and essential performance - Collateral standard:
Electromagnetic disturbances -- requirements and tests (Recognition Number 19-12).
IEC 60601-
Electrical Safety Tests: The Electrical Safety Tests have been performed according to
1:2005, Medical electrical equipment - Part 1: General requirements for basic safety and
essential performance (General). (Recognition Number 5-71) included USA and Canadian
Deviations.
Software Verification and Validation: Software Verification and Validation activities were conducted
and documented according to the document named “Guidance for Industry and FDA Staff - Guidance
for the Content of Premarket Submissions for Software Contained in Medical Devices” dated May 11,
2005.
Performance Testing bench: The comparison of performances between PIEZOTOME CUBE and
Predicate Device has been performed. The Technical Characteristics for PIEZOTOME CUBE
(Piezoelectric Performances, Frequency Modulations and Irrigation Performances) are similar as the
Predicate Device PIEZOTOME SOLO (K112188, cleared February 03, 2012).
Sterilization Validation: The Sterilizability Tests of SATELEC CUBE LED Handpiece have been
performed according to applicable Standards for Re-Usable accessories (i.e., ISO 17665-1, ISO
17665-2, AAMI ST55, and AAMI TIR 30).
Cleaning Validation: Cleaning validation of the PIEZOTOME CUBE was conducted per the
FDA Guidance Document entitled, “Reprocessing Medical Devices in Health Care Settings:
Validation Methods and Labeling” dated March 17, 2015.
Biocompatibility Validation: The Biocompatibility Tests have been performed according to applicable
Standards for Accessories in contact to the Patient. Tests were conducted according to the ISO 10993-
1 Standard and 510(k) Memorandum - #G95-1 Table 1 “Initial Evaluation Tests for Consideration
VIII –CONCLUSION
Following all information contained in this Pre-Market Notification Submission File, we can declare that
the SATELEC PIEZOTOME CUBE is Substantially Equivalent (SE) to the SATELEC Predicate Device
PIEZOTOME SOLO (K112188, cleared February 03, 2012).
End of Section
(No other information after this line expect Appendix if applicable)